Stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau in cellular and mouse models of tauopathies

References

• Bayer TA, Wirths O. Intracellular accumulation of amyloid-beta - a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Front Aging Neurosci. 2010;2:1–10.
   PubMed Web of Science ®Google Scholar
• Gouras GK, Tampellini D, Takahashi RH, et al. Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer’s disease. Acta Neuropathol. 2010;119:523–541.
   PubMed Web of Science ®Google Scholar
• Tai HC, Serrano-Pozo A, Hashimoto T, et al. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol. 2012;181:1426–1435.
   PubMed Web of Science ®Google Scholar
• Coleman PD, Yao PJ. Synaptic slaughter in Alzheimer’s disease. Neurobiol Aging. 2003;24:1023–1027.
   PubMed Web of Science ®Google Scholar
• DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann Neurol. 1990;27:457–464.
   PubMed Web of Science ®Google Scholar
• Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572–580.
   PubMed Web of Science ®Google Scholar
• Reiman EM, Chen K, Alexander GE, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia. Proc Natl Acad Sci U S A. 2004;101:284–289.
   PubMed Web of Science ®Google Scholar
• Sperling RA, Laviolette PS, O’Keefe K, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron. 2009;63:178–188.
   PubMed Web of Science ®Google Scholar
• O’Brien JL, O’Keefe KM, LaViolette PS, et al. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology. 2010;74:1969–1976.
   PubMed Web of Science ®Google Scholar
• Coomans EM, Schoonhoven DN, Tuncel H, et al. In vivo tau pathology is associated with synaptic loss and altered synaptic function. Alzheimers Res Ther. 2021;13:35.
   PubMed Web of Science ®Google Scholar
• Ramirez AE, Pacheco CR, Aguayo LG, et al. Rapamycin protects against Abeta-induced synaptotoxicity by increasing presynaptic activity in hippocampal neurons. Biochim Biophys Acta. 2014;1842:1495–1501.
   PubMed Web of Science ®Google Scholar
• Tampellini D, Rahman N, Gallo EF, et al. Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci. 2009;29:9704–9713.
   PubMed Web of Science ®Google Scholar
• Lam J, Lee J, Liu CY, et al. Deep brain stimulation for alzheimer’s disease: tackling circuit dysfunction. Neuromodulation. 2021;24:171–186.
   PubMed Web of Science ®Google Scholar
• Tampellini D. Synaptic activity and Alzheimer’s disease: a critical update. Front Neurosci. 2015;9:423.
   PubMed Web of Science ®Google Scholar
• Akwa Y, Gondard E, Mann A, et al. Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation. Mol Psychiatry. 2018;23:1530–1540.
   PubMed Web of Science ®Google Scholar
• Mann A, Gondard E, Tampellini D, et al. Chronic deep brain stimulation in an Alzheimer’s disease mouse model enhances memory and reduces pathological hallmarks. Brain Stimul. 2018;11:435–444.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, etal. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2021;17(1):1–382.
   PubMed Web of Science ®Google Scholar
• Napolitano G, Ballabio A. TFEB at a glance. J Cell Sci. 2016;129(13):2475–2481.
   PubMed Web of Science ®Google Scholar
• Settembre C, Di Malta C, Polito VA, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332:1429–1433.
   PubMed Web of Science ®Google Scholar
• Settembre C, Zoncu R, Medina DL, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 2012;31:1095–1108.
   PubMed Web of Science ®Google Scholar
• Sardiello M, Palmieri M, Di Ronza A, et al. A gene network regulating lysosomal biogenesis and function. Science. 2009;325:473–477.
   PubMed Web of Science ®Google Scholar
• Becot A, Pardossi-Piquard R, Bourgeois A, et al. The transcription factor EB reduces the intraneuronal accumulation of the beta-secretase-derived app fragment C99 in cellular and mouse Alzheimer’s Disease models. Cells. 2020;9:1204.
   PubMed Web of Science ®Google Scholar
• Polito VA, Li H, Martini-Stoica H, et al. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol Med. 2014;6:1142–1160.
   PubMed Web of Science ®Google Scholar
• Rusmini P, Cortese K, Crippa V, et al. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. Autophagy. 2019;15:631–651.
   PubMed Web of Science ®Google Scholar
• Nalls MA, Pankratz N, Lill CM, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet. 2014;46:989–993.
   PubMed Web of Science ®Google Scholar
• Lei P, Ayton S, Finkelstein DI, et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med. 2012;18:291–295.
   PubMed Web of Science ®Google Scholar
• Yoshiyama Y, Higuchi M, Zhang B, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron. 2007;53:337–351.
   PubMed Web of Science ®Google Scholar
• Ehlers MD. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci. 2003;6:231–242.
   PubMed Web of Science ®Google Scholar
• Martina JA, Diab HI, Lishu L, et al. The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci Signal. 2014;7:ra9.
   PubMed Web of Science ®Google Scholar
• Lisman J, Yasuda R, Raghavachari S. Mechanisms of CaMKII action in long-term potentiation. Nat Rev Neurosci. 2012;13:169–182.
   PubMed Web of Science ®Google Scholar
• Rabanal-Ruiz Y, Otten EG, Korolchuk VI, et al. mTORC1 as the main gateway to autophagy. Essays Biochem. 2017;61:565–584.
   PubMed Web of Science ®Google Scholar
• Guertin DA, Sabatini DM. The pharmacology of mTOR inhibition. Sci Signal. 2009;2:24. pe.
   Web of Science ®Google Scholar
• Sancak Y, Peterson TR, Shaul YD, et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science. 2008;320:1496–1501.
   PubMed Web of Science ®Google Scholar
• Napolitano G, Di Malta C, Esposito A, et al. A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dube syndrome. Nature. 2020;585:597–602.
   PubMed Web of Science ®Google Scholar
• Stone SS, Teixeira CM, Devito LM, et al. Stimulation of entorhinal cortex promotes adult neurogenesis and facilitates spatial memory. J Neurosci. 2011;31:13469–13484.
   PubMed Web of Science ®Google Scholar
• Jellinger KA. Interaction between alpha-synuclein and tau in Parkinson’s disease comment on Wills et al.: elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson’s disease brains with and without dementia. Exp Neurol. 2011; 227: 13-8 2010;225:210–218
   PubMedGoogle Scholar
• Moussaud S, Jones DR, Moussaud-Lamodiere EL, et al. Alpha-synuclein and tau: teammates in neurodegeneration? Mol Neurodegener. 2014;9:43.
   PubMed Web of Science ®Google Scholar
• Zhang X, Gao F, Wang D, et al. Tau Pathology in Parkinson’s Disease. Front Neurol. 2018;9:809.
   PubMedGoogle Scholar
• Djajadikerta A, Keshri S, Pavel M, et al. Autophagy induction as a therapeutic strategy for neurodegenerative diseases. J Mol Biol. 2019;432:2799–2821.
   PubMed Web of Science ®Google Scholar
• Cataldo AM, Petanceska S, Terio NB, et al. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and down syndrome. Neurobiol Aging. 2004;25:1263–1272.
   PubMed Web of Science ®Google Scholar
• Ihara Y, Morishima-Kawashima M, Nixon R. The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2:2–27.
   Web of Science ®Google Scholar
• Maxfield FR. Role of endosomes and lysosomes in human disease. Cold Spring Harb Perspect Biol. 2014;6:a016931.
   PubMed Web of Science ®Google Scholar
• Hamano T, Gendron TF, Causevic E, et al. Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. Eur J Neurosci. 2008;27:1119–1130.
   PubMed Web of Science ®Google Scholar
• Brunden KR, Trojanowski JQ, Lee VM. Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments. J Alzheimers Dis. 2008;14:393–399.
   PubMed Web of Science ®Google Scholar
• Marx J. Alzheimer’s disease. A new take on tau. Science. 2007;316:1416–1417.
   PubMed Web of Science ®Google Scholar
• Maeda S, Sahara N, Saito Y, et al. Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer’s disease. Neurosci Res. 2006;54:197–201.
   PubMed Web of Science ®Google Scholar
• Spires-Jones TL, Hyman BT. The intersection of amyloid beta and tau at synapses in Alzheimer’s disease. Neuron. 2014;82:756–771.
   PubMed Web of Science ®Google Scholar
• Schaeffer V, Goedert M. Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy. Autophagy. 2012;8:1686–1687.
   PubMed Web of Science ®Google Scholar
• Caccamo A, Ferreira E, Branca C, et al. p62 improves AD-like pathology by increasing autophagy. Mol Psychiatry. 2016;22:865–873.
   PubMed Web of Science ®Google Scholar
• Ejlerskov P, Ashkenazi A, Rubinsztein DC. Genetic enhancement of macroautophagy in vertebrate models of neurodegenerative diseases. Neurobiol Dis. 2019;122:3–8.
   PubMed Web of Science ®Google Scholar
• Bordi M, Berg MJ, Mohan PS, et al. Autophagy flux in CA1 neurons of Alzheimer hippocampus: increased induction overburdens failing lysosomes to propel neuritic dystrophy. Autophagy. 2016;12:2467–2483.
   PubMed Web of Science ®Google Scholar
• Menzies FM, Fleming A, Caricasole A, et al. Autophagy and Neurodegeneration: pathogenic Mechanisms and Therapeutic Opportunities. Neuron. 2017;93:1015–1034.
   PubMed Web of Science ®Google Scholar
• Zheng X, Lin W, Jiang Y, et al. Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB). Autophagy. 2021;17(11):1–15.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Davies JE, Huang Z, et al. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem. 2007;282:5641–5652.
   PubMed Web of Science ®Google Scholar
• Xu Y, Du S, Marsh JA, et al. TFEB regulates lysosomal exocytosis of tau and its loss of function exacerbates tau pathology and spreading. Mol Psychiatry. 2021;26:5925–5939.
   PubMed Web of Science ®Google Scholar
• Bagh MB, Peng S, Chandra G, et al. Misrouting of v-ATPase subunit V0a1 dysregulates lysosomal acidification in a neurodegenerative lysosomal storage disease model. Nat Commun. 2017;8:14612.
   PubMed Web of Science ®Google Scholar
• Hassiotis S, Manavis J, Blumbergs PC, et al. Lysosomal LAMP1 immunoreactivity exists in both diffuse and neuritic amyloid plaques in the human hippocampus. Eur J Neurosci. 2018;47:1043–1053.
   PubMed Web of Science ®Google Scholar
• Piras A, Collin L, Gruninger F, et al. Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol Commun. 2016;4:22.
   PubMed Web of Science ®Google Scholar
• Burket JA, Benson AD, Tang AH, et al. NMDA receptor activation regulates sociability by its effect on mTOR signaling activity. Prog Neuropsychopharmacol Biol Psychiatry. 2015;60:60–65.
   PubMed Web of Science ®Google Scholar
• Medina DL, Di Paola S, Peluso I, et al. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat Cell Biol. 2015;17:288–299.
   PubMed Web of Science ®Google Scholar
• Snyder EM, Nong Y, Almeida CG, et al. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci. 2005;8:1051–1058.
   PubMed Web of Science ®Google Scholar
• Lu W, Man H, Ju W, et al. Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron. 2001;29:243–254.
   PubMed Web of Science ®Google Scholar
• McKinnon C, Gros P, Lee DJ, et al. Deep brain stimulation: potential for neuroprotection. Ann Clin Transl Neurol. 2018;6:174–185.
   PubMed Web of Science ®Google Scholar
• Jakobs M, Lee DJ, Lozano AM. Modifying the progression of Alzheimer’s and Parkinson’s disease with deep brain stimulation. Neuropharmacology. 2020;171:107860.
   PubMed Web of Science ®Google Scholar
• Wills J, Jones J, Haggerty T, et al. Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson’s disease brains with and without dementia. Exp Neurol. 2010;225:210–218.
   PubMed Web of Science ®Google Scholar
• Muntane G, Dalfo E, Martinez A, et al. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related alpha-synucleinopathies. Neuroscience. 2008;152:913–923.
   PubMed Web of Science ®Google Scholar
• Musacchio T, Rebenstorff M, Fluri F, et al. Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T alpha-synuclein Parkinson’s disease rat model. Ann Neurol. 2017;81:825–836.
   PubMed Web of Science ®Google Scholar
• Leplus A, Lauritzen I, Melon C, et al. Chronic fornix deep brain stimulation in a transgenic Alzheimer’s rat model reduces amyloid burden, inflammation, and neuronal loss. Brain Struct Funct. 2019;224:363–372.
   PubMed Web of Science ®Google Scholar
• Decressac M, Mattsson B, Weikop P, et al. TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc Natl Acad Sci U S A. 2013;110:E1817–26.
   PubMed Web of Science ®Google Scholar
• Sankar T, Chakravarty MM, Bescos A, et al. Deep brain stimulation influences brain structure in Alzheimer’s Disease. Brain Stimul. 2015;8:645–654.
   PubMed Web of Science ®Google Scholar
• Reese R, Leblois A, Steigerwald F, et al. Subthalamic deep brain stimulation increases pallidal firing rate and regularity. Exp Neurol. 2011;229:517–521.
   PubMed Web of Science ®Google Scholar
• Moran A, Stein E, Tischler H, et al. Dynamic stereotypic responses of basal ganglia neurons to subthalamic nucleus high-frequency stimulation in the parkinsonian primate. Front Syst Neurosci. 2011;5:21.
   PubMedGoogle Scholar
• Filali M, Hutchison WD, Palter VN, et al. Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus. Exp Brain Res. 2004;156:274–281.
   PubMed Web of Science ®Google Scholar
• Welter ML, Houeto JL, Bonnet AM, et al. Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients. Arch Neurol. 2004;61:89–96.
   PubMedGoogle Scholar
• Dostrovsky JO, Lozano AM. Mechanisms of deep brain stimulation. Mov Disord. 2002;17(3):S63–8.
   PubMedGoogle Scholar
• Chiken S, Nambu A. Mechanism of deep brain stimulation: inhibition, excitation, or disruption? Neuroscientist. 2016;22:313–322.
   PubMed Web of Science ®Google Scholar
• Oddo S, Caccamo A, Shepherd JD, et al. Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39:409–421.
   PubMed Web of Science ®Google Scholar
• Settembre C, Medina DL. TFEB and the CLEAR network. Methods Cell Biol. 2015;126:45–62.
   PubMed Web of Science ®Google Scholar
• Crowe AR, Yue W. Semi-quantitative determination of protein expression using Immunohistochemistry staining and analysis: an integrated protocol. Biol Protoc. 2019;9:1–11.
   Web of Science ®Google Scholar
• Tampellini D, Capetillo-Zarate E, Dumont M, et al. Effects of synaptic modulation on {beta}-amyloid, synaptophysin, and memory performance in Alzheimer’s Disease transgenic mice. J Neurosci. 2010;30:14299–14304.
   PubMed Web of Science ®Google Scholar